141 related articles for article (PubMed ID: 10381522)
1. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation.
Landowski TH; Shain KH; Oshiro MM; Buyuksal I; Painter JS; Dalton WS
Blood; 1999 Jul; 94(1):265-74. PubMed ID: 10381522
[TBL] [Abstract][Full Text] [Related]
2. Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line.
Shain KH; Landowski TH; Buyuksal I; Cantor AB; Dalton WS
Leukemia; 2000 May; 14(5):830-40. PubMed ID: 10803514
[TBL] [Abstract][Full Text] [Related]
3. Selection for drug resistance results in resistance to Fas-mediated apoptosis.
Landowski TH; Gleason-Guzman MC; Dalton WS
Blood; 1997 Mar; 89(6):1854-61. PubMed ID: 9058704
[TBL] [Abstract][Full Text] [Related]
4. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic drugs and the CD95 pathway.
Friesen C; Fulda S; Debatin KM
Leukemia; 1999 Nov; 13(11):1854-8. PubMed ID: 10557062
[TBL] [Abstract][Full Text] [Related]
6. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH
Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521
[TBL] [Abstract][Full Text] [Related]
7. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.
Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K
Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation.
Bian X; Giordano TD; Lin HJ; Solomon G; Castle VP; Opipari AW
J Biol Chem; 2004 Feb; 279(6):4663-9. PubMed ID: 14617634
[TBL] [Abstract][Full Text] [Related]
9. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda S; Sieverts H; Friesen C; Herr I; Debatin KM
Cancer Res; 1997 Sep; 57(17):3823-9. PubMed ID: 9288794
[TBL] [Abstract][Full Text] [Related]
10. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells.
Friesen C; Fulda S; Debatin KM
Leukemia; 1997 Nov; 11(11):1833-41. PubMed ID: 9369415
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).
Los M; Herr I; Friesen C; Fulda S; Schulze-Osthoff K; Debatin KM
Blood; 1997 Oct; 90(8):3118-29. PubMed ID: 9376593
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of apoptosis induced by cytotoxic drugs.
Fulda S; Friesen C; Debatin KM
Klin Padiatr; 1998; 210(4):148-52. PubMed ID: 9743944
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis.
Posovszky C; Friesen C; Herr I; Debatin KM
Leukemia; 1999 Mar; 13(3):400-9. PubMed ID: 10086731
[TBL] [Abstract][Full Text] [Related]
14. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells.
Tong AW; Seamour B; Chen J; Su D; Ordonez G; Frase L; Netto G; Stone MJ
Leuk Lymphoma; 2000 Feb; 36(5-6):543-58. PubMed ID: 10784400
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide.
Tu Y; Xu FH; Liu J; Vescio R; Berenson J; Fady C; Lichtenstein A
Blood; 1996 Sep; 88(5):1805-12. PubMed ID: 8781438
[TBL] [Abstract][Full Text] [Related]
17. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation.
Boesen-de Cock JG; Tepper AD; de Vries E; van Blitterswijk WJ; Borst J
J Biol Chem; 1999 May; 274(20):14255-61. PubMed ID: 10318846
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy primes malignant glioma cells for CD95 ligand-induced apoptosis up-stream of caspase 3 activation.
Hueber A; Winter S; Weller M
Eur J Pharmacol; 1998 Jul; 352(1):111-5. PubMed ID: 9718275
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system.
McGahon AJ; Costa Pereira AP; Daly L; Cotter TG
Br J Haematol; 1998 Jun; 101(3):539-47. PubMed ID: 9633899
[TBL] [Abstract][Full Text] [Related]
20. Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells.
Dorothee G; Ameyar M; Bettaieb A; Vergnon I; Echchakir H; Bouziane M; Chouaib S; Mami-Chouaib F
Int J Cancer; 2001 Mar; 91(6):772-7. PubMed ID: 11275978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
